Alkem Laboratories has launched Renocia Exo, a next-generation hair regeneration therapy designed to scientifically support and vitalise hair follicles.

Hair loss is now one of India’s fastest-growing dermatological issues, rapidly affecting younger generations alongside aging adults. Modern research shows that hair thinning is driven by a complex mix of genetics, lifestyle shifts, environmental stressors, and changing health patterns. However, despite a growing market of treatment options, most standard therapies still fail because they target only a single aspect of the hair growth cycle rather than addressing these interconnected biological causes.

Commenting on the launch, Sandeep Singh, Managing Director, Alkem, said, “The science of hair restoration has evolved significantly over the last decade, and so has our understanding of what drives progressive hair thinning. It is influenced by multiple biological processes, including follicular miniaturization, altered cellular signalling, oxidative stress, inflammation, and changes within the follicular microenvironment. This evolving understanding calls for equally evolved therapeutic solutions. With Renocia Exo, we bring together multiple regenerative technologies to support the biology of the hair follicle in a single daily therapy.”

Renocia Exo goes beyond standard topical treatments that just stimulate hair growth; instead, it supports the multiple biological processes needed for healthy hair follicles.

The formulation also focuses on supporting multiple signalling pathways involved in hair follicle activity while promoting a favourable environment for healthier, stronger hair over time.

Its lightweight, cosmetically elegant composition is free from alcohol, sulphates, silicones parabens and mineral oil, making it suitable for regular use as part of dermatologist-guided hair loss management.